Bibo Tan
Papers
2
Total Citations
52
H-Index
2
About
Bibo Tan is a surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly through robotic and laparoscopic approaches. Dr. Tan’s major contributions center on optimizing lymph node dissection—a critical factor in gastric cancer prognosis—by comparing novel tracer technologies and surgical platforms. In their most cited work (35 citations), Dr. Tan conducted a comparative analysis of carbon nanoparticle suspension injection (CNSI) versus indocyanine green (ICG) tracer-guided lymph node dissection during robotic distal gastrectomy, providing crucial evidence on perioperative safety and detection efficacy. This study helps surgeons select the optimal tracer for precise nodal staging. Additionally, Dr. Tan performed a meta-analysis (17 citations) systematically evaluating the efficacy of Da Vinci robotic versus laparoscopic distal subtotal gastrectomy, offering valuable insights into the benefits of robotic assistance in terms of surgical outcomes. By bridging the gap between emerging tracer technologies and advanced surgical robotics, Dr. Tan’s work directly informs clinical decision-making and enhances the precision of gastric cancer surgery, making a tangible impact on patient care in oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2